Navigation Links
Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
Date:4/27/2010

es of Seroquel, and paid doctors to give promotional lectures to other health care professionals about unapproved and unaccepted uses of Seroquel.  The United States contends that these payments were intended to induce the doctors to prescribe Seroquel for unapproved uses in violation of the federal Anti-Kickback Statute.

"Rooting out health care fraud is a top priority for the Obama Administration, said Kathleen Sebelius, Secretary of the Department of Health and Human Services. "Today's settlement sends a clear warning to any individual or company seeking to defraud our health care system and returns hundreds of millions of dollars of taxpayer money to the Medicare trust fund where they belong. It reflects the unprecedented energy, resources, and new ideas that this administration has devoted to identifying, prosecuting, and ultimately preventing health care fraud. With the new anti-healthcare fraud resources in the Affordable Care Act, there has never been a worse time to try to steal from our health care system."

"Consumers are entitled to rely on the claims pharmaceutical companies make about the drugs they sell," said Tony West, Assistant Attorney General for the Civil Division of the Department of Justice. "Working with our federal and state partners, we will protect the integrity of our public health programs by ensuring that kickbacks from drug companies do not taint the medical decisions of health care professionals."

"When pharmaceutical companies interfere with the FDA's mission to insure that drugs are safe and effective, they undermine the doctor-patient relationship and put the health and safety of patients at risk," said Michael L. Levy, U.S. Attorney for the Eastern District of Pennsylvania.  "People have a legal right t
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
(Date:11/26/2014)... 2014 Investor-Edge has initiated coverage on ... Horizon Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. ... JNJ ), and Theravance Inc. (NASDAQ: THRX ... at: http://investor-edge.com/register . On Tuesday, November 25, ... Dow Jones Industrial Average edged 0.02% lower, to finish the ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
Breaking Medicine Technology:Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... bioMerieux, a world leader in the field of in ... that most critical care nurses are unaware of a simple ... The survey, conducted at the 2010 American Association of Critical ... of nurses expressed the need for new tools to battle ...
... 21, 2010 INVO Bioscience, Inc. (OTC Bulletin Board: ... on treatment options for patients diagnosed with infertility, today ... Bolivia.  The initial order of INVOcell devices was purchased ... Under the direction of clinic director Dr. Joaquin Lopez ...
Cached Medicine Technology:Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis 2Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis 3INVO Bioscience Announces First Shipments of INVOcell Into Bolivia 2INVO Bioscience Announces First Shipments of INVOcell Into Bolivia 3
(Date:11/28/2014)... Pittsburgh, PA (PRWEB) November 28, 2014 An ... individuals have day to day. "I got this idea while ... walk to the bathroom," he said. , The Bed Buddy ... person to go to the bathroom. It eliminates the need ... well as promotes comfort and dignity. Easy to use and ...
(Date:11/28/2014)... 2014 ARTAS robotic hair transplant surgical ... time. PAI Medical Group hair transplant surgeons Chris Pawlinga, ... robotic hair transplant procedure in the Brentwood office on ... first in Tennessee and one of only three medical ... ARTAS robotic hair transplantation. Patients benefit from this minimally ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Based in ... organization focused on delivering exemplary solutions to the income ... ancillary benefits. In an effort to extend its reach ... and asset protection, Secura Consultants has brought aboard financial ... , “I am a big believer in specialization. When ...
(Date:11/28/2014)... TheBeautyPlace.com does it ... offering savings in abundance this retail season. , ... and cosmetic products such as SkinMedica, Neocutis, Glo ... competitive discounts on already reduced prices. At TheBeautyPlace.com ... giving customers savings year round. , TheBeautyPlace.com's Black ...
(Date:11/27/2014)... Albany, NY (PRWEB) November 28, 2014 ... industry is implant dentistry. The market for implant ... as supporting tools/instruments. The global market for dental ... and dental equipments. The dental equipment segment is ... with table of contents at: http://www.researchmoz.us/global-dental-market-report-2014-edition-report.html ...
Breaking Medicine News(10 mins):Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Matt Lee, CLU, ChFC Joins Secura Consultants as New Brokerage Consultant 2Health News:TheBeautyPlace.com Announces Double Savings 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 3
... A device consisting of a giant rubber tube may hold ... sea waves. , Invented in the UK, the ,Anaconda, is ... it would be cheap to manufacture and maintain, enabling it ... of wave energy converter. Cost has been a key barrier ...
... BEACH, Va., July 3 AMERIGROUP,Corporation (NYSE: AGP ... renewed its contract with the State of Tennessee,through June ... for the period April 1, 2008,through June 30, 2008, ... July 1,2008 through June 30, 2009. Expenditures on home ...
... July 3 Mylan Inc. (NYSE: MYL ... has,received tentative approval from the U.S. Food and ... (ANDA) for Linezolid,Tablets, 600 mg., Linezolid Tablets, ... Upjohn,s Zyvox(R) Tablets, which had U.S. sales of ...
... Rigel Pharmaceuticals,Inc. (Nasdaq: RIGL ) today announced that ... will present a company overview,at the Fourth Annual Collins ... a.m. EDT at The Mandarin Oriental Hotel in New ... or the subsequent archived recording,log on to http://www.rigel.com ...
... AND DUSK, DRAIN, SACRAMENTO, Calif., July 2 ... families and friends gathering outdoors, the,Mosquito and Vector ... take precautions against West Nile virus., "Individuals ... to prevent the spread of West Nile Virus ...
... long-term studies to assure medications don,t raise cardiovascular risks, ... to control type 2 diabetes should be subjected to ... the risk of heart problems, U.S. Food and Drug ... experts voted 14-to-2, at the end of a two-day ...
Cached Medicine News:Health News:Rubber 'snake' could help wave power get a bite of the energy market 2Health News:AMERIGROUP Renews Contract with Tennessee 2Health News:Remember West Nile Virus Safety This Fourth of July 2Health News:FDA Panel Calls for More Testing of Diabetes Drugs 2Health News:FDA Panel Calls for More Testing of Diabetes Drugs 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: